Glycemic Control in People with Type 2 Diabetes (PWT2D) Switching from NPH to Insulin Glargine 300 U/mL (Gla-300) : REALI Pooled Database

被引：0
|
作者：
Mueller-Wieland, Dirk
Freemantle, Nick
Bonadonna, Riccardo C.
Mauquoi, Celine
Bigot, Gregory
Bonnemaire, Mireille
Gourdy, Pierre
Mauricio, Didac
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-807-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
807-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Glycaemic control in people with type 2 diabetes (T2D) switching from NPH to insulin glargine 300 U/mL (Gla-300): REALI pooled database
    Mueller-Wieland, D.
    Freemantle, N.
    Bonadonna, R.
    Mauquoi, C.
    Bigot, G.
    Bonnemaire, M.
    Gourdy, P.
    Mauricio, D.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S333 - S334
  • [2] Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
    Mueller-Wieland, Dirk
    Freemantle, Nick
    Bonadonna, Riccardo C.
    Mauquoi, Celine
    Bigot, Gregory
    Bonnemaire, Mireille
    Gourdy, Pierre
    Mauricio, Didac
    DIABETES THERAPY, 2023, 14 (02) : 401 - 413
  • [3] Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
    Dirk Müller-Wieland
    Nick Freemantle
    Riccardo C. Bonadonna
    Celine Mauquoi
    Gregory Bigot
    Mireille Bonnemaire
    Pierre Gourdy
    Didac Mauricio
    Diabetes Therapy, 2023, 14 : 401 - 413
  • [4] Factors Associated with Glycemic Control in People with Type 1 Diabetes (PWT1D) Switched to Once Daily (QD) Insulin Glargine (Gla) 300 U/mL (Gla-300): The European REALI Pooled Database
    Mueller-Wieland, Dirk
    Gourdy, Pierre
    Bonadonna, Riccardo C.
    Freemantle, Nick
    Bigot, Gregory
    Jamoul, Corinne
    Ciocca, Alice
    Bonnemaire, Mireille
    Mauricio, Didac
    DIABETES, 2021, 70
  • [5] Gender differences in achieving glycaemic control in patients with type 2 diabetes initiated on insulin glargine 300 U/ml (Gla-300): the European REALI pooled database
    Bonnemaire, M.
    Bonadonna, R.
    Freemantle, N.
    Mauricio, D.
    Muller-Wieland, D.
    Bigot, G.
    Mauquois, C.
    Ciocca, A.
    Gourdy, P.
    DIABETOLOGIA, 2019, 62 : S439 - S439
  • [6] The efficacy of switching from Insulin Glargine 100 U/mL (Gla-100) to Insulin Glargine 300 U/mL (Gla-300) in patients with type 2 diabetes mellitus
    Yang, K. -H.
    Tseng, C. -T.
    Chen, L. -C.
    Chen, P. -C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 310 - 310
  • [7] Controlling glycemic variability in people living with type 1 diabetes receiving insulin glargine 300 U/mL (Gla-300)
    Mader, Julia K.
    Goelz, Stefan
    Bilz, Stefan
    Bramlage, Peter
    Danne, Thomas
    BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (04)
  • [8] Older people with type 2 diabetes: glycaemic control and hypoglycaemia risk with new insulin glargine 300 U/ml (Gla-300)
    Stella, P.
    Aroda, V.
    Charbonnel, B.
    Ritzel, R.
    Merino-Trigo, A.
    Grisoni, M. -L.
    Sinclair, A. J.
    Yale, J. -F.
    DIABETOLOGIA, 2015, 58 : S473 - S473
  • [9] New insulin glargine 300U/ml (Gla-300): glycaemic control and hypoglycaemia in insulin-naive people with Type 2 diabetes compared with glargine 100U/ml (Gla-100)
    Bolli, G. B.
    Riddle, M. C.
    Bergenstal, R. M.
    Sestakauskas, K.
    Goyeau, H.
    Home, P. D.
    DIABETIC MEDICINE, 2015, 32 : 78 - 78
  • [10] Is hypoglycaemia a modifiable patient risk in type 2 diabetes: A pooled analysis of insulin glargine 300 U/mL (Gla-300) vs 100U/mL (Gla-100) trials?
    Zhang, Q.
    Rosenstock, J.
    Gerrits, C.
    Liao, L.
    Chew, P.
    DIABETOLOGIA, 2015, 58 : S472 - S472
12345